What is NDC 0024-5824?

0024-5824 is the product NDC for Jevtana (cabazitaxel) kit, listed with the FDA by Sanofi-Aventis U.S. LLC. It has 1 package NDC, shown above in 10- and 11-digit form.

Sanofi-Aventis U.S. LLC, NDC labeler code 0024. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Jevtana?

None: this is the only finished product listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Jevtana NDC 0024-5824 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)0024-5824Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00024-5824Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
0024-5824-11	0002458241100024582411	1 KIT in 1 CARTON (0024-5824-11) * 5.7 mL in 1 VIAL, GLASS (0024-5823-15) * 5.7 mL in 1 VIAL, GLASS (0024-5822-01)Marketed from Jun 17, 2010

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Jevtana
Generic name (nonproprietary): cabazitaxel
Dosage form: Kit
Labeler: Sanofi-Aventis U.S. LLCNDC labeler code 0024
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 201023
Marketing start: Jun 17, 2010
Listing expires: Dec 31, 2026
Identifiers: Product ID 0024-5824_66314b60-5135-400e-933a-d4974397fdaaSPL ID 66314b60-5135-400e-933a-d4974397fdaaSPL set ID de3d9c26-572b-4ea4-9b2d-dd58a2b3e8faRxCUI 1001433, 1376084

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

NDC on a medical claim

N400024582411 followed by a unit qualifier and the quantity

Package 00024-5824-11. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Oct 7, 2025. This label includes a boxed warning.

Indications (excerpt from the label)

JEVTANA ® is indicated in combination with prednisone for the treatment of patients with metastatic castration-resistant prostate cancer previously treated with a docetaxel-containing treatment regimen. JEVTANA is a microtubule inhibitor indicated in combination with prednisone for treatment of patients with metastatic castration-resistant prostate cancer previously treated with a docetaxel-containing treatment regimen. ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 0024-5824

What is NDC 0024-5824?: 0024-5824 is the product NDC for Jevtana (cabazitaxel) kit, listed with the FDA by Sanofi-Aventis U.S. LLC. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Jevtana (Cabazitaxel).
Who is the labeler?: Sanofi-Aventis U.S. LLC, NDC labeler code 0024. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Jevtana?: None: this is the only finished product listed under this name.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Jevtana (Cabazitaxel) NDC 0024-5824